COMMUNIQUÉS West-GlobeNewswire

CellaVision AB presents the second quarter 2017 on July 18 at 11:00 CET
04/07/2017
Pdf This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Sanofi : Disclosure of trading in own shares
03/07/2017
Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Sanofi : Déclaration des transactions sur actions propres
03/07/2017
Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Ossur Hf : Transactions in relation to share buyback program
03/07/2017
Announcement from Össur hf. No. 47/2017 Reykjavík, 3 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
NICOX : Déclaration des droits de vote au 30 juin 2017
03/07/2017
Nicox SA Société anonyme au capital de 25 669 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 juillet 2017, PUBLICATION MENSUELLE DU NOMBRE D' [...]
NICOX : Number of voting rights as of June 30. 2017
03/07/2017
Nicox SA Société anonyme with a registered capital of € 25,669,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On July 3, 2017, MONTHLY PUBLICATION OF THE [...]
IBA SA : IBA - NOTIFICATION DE TRANSPARENCE
03/07/2017
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 3 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
IBA SA : IBA - TRANSPARENCY NOTIFICATION
03/07/2017
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 03, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]
Une nouvelle étude avec la pompe cardiaque Impella 2.5® d'Abiomed démontre une survie potentielle avec l'insertion pré ICP dans les crises cardiaques avec l'artère coronaire principale gauche
03/07/2017
DANVERS, Massachusetts, July 3, 2017 (GLOBE NEWSWIRE) - Abiomed, Inc . (NASDAQ : ABMD), fournisseur majeur de technologies innovantes d'assistance et de récupération cardiaque, a annoncé aujourd'hui la publication [...]
Shire plc : Director/PDMR Shareholding
03/07/2017
Director/PDMR Shareholding July 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Bavarian Nordic Issues Warrants to Newly Appointed Member of the Executive Management
03/07/2017
COPENHAGEN, Denmark, July 3, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the Board of Directors in Bavarian Nordic A/S has decided to issue warrants to Tommi Kainu, newly appointed Chief [...]
Status regarding Novo Nordisk's holding of its own shares (30 June 2017)
03/07/2017
Bagsværd, Denmark, 3 July 2017 - In continuation of the company's announcements dated 2 February 2017 and 3 May 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock [...]
Novo Nordisk A/S - Share repurchase programme
03/07/2017
Bagsværd, Denmark, 3 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval of an oncology companion diagnostic test with leading next generation sequencing company
03/07/2017
Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval of an oncology companion diagnostic test with leading next generation sequencing company Horizon's reference standards [...]
Shire plc : Total voting rights
03/07/2017
Total Voting Rights July 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies the [...]
Solon Eiendom ASA : Sales in Q2 2017
03/07/2017
SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Sales in Q2 2017 Oslo, July 3, 2017 - Solon Eiendom sold 68 homes with a total sales value of NOK 685 million during the second quarter of 2017 compared [...]
Total number of shares and voting rights in Zealand at June 30, 2017
03/07/2017
Company announcement - No. 24 / 2017 Total number of shares and voting rights in Zealand at June 30, 2017 Copenhagen, July 3, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure [...]
Zealand initiates first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
03/07/2017
Company announcement - No. 23/2017 Zealand initiates first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes First patients enrolled in a multinational Phase 3 clinical trial of [...]
Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline
03/07/2017
PRESS RELEASE Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline (Oxford, UK and Conshocken, US, 3 July 2017) Immunocore Limited, the world's leading TCR company [...]

Pages